Wockhardt in the limelight
By
Research Desk
about 8 years ago
Wockhardt is in the limelight today morning. The stock which has closed yesterday at Rs.894.45, opened at Rs.920, going up to an intra day high of Rs.936.95. The stock now remains 3.5% in the green at Rs.925 levels.
For once there is good news from Wockhardt and that too coming from US FDA. The company stated yesterday after market hours that regarding the import alert on its API Unit at Ankleshwar, the US FDA on 30th Sept posted on its website an update on the above referred matter and excluded the product “Ceftriazone Sodium” from Import Alert.
This will now enable the company to manufacture and sell Ceftriazone API and formulation to US.